ArticleBMC gastroenterology2022

Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.

Benjamin Click et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.